Changchun BCHT Biotechnology Co.

688276

CNE100005XY6

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-06-13 EDT			5-day change	1st Jan Change
31.41 ^CNY	-1.78%		+0.83%	-42.69%

04-24	Chinese Drug Regulator Accepts BCHT Biotechnology's Marketing Application for Influenza Nasal Spray Vaccine	MT
04-19	Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Changchun BCHT Biotechnology Co.(XSSC:688276) added to S&P Global BMI Index

September 18, 2023 at 12:00 am

Latest news about Changchun BCHT Biotechnology Co.

Chinese Drug Regulator Accepts BCHT Biotechnology's Marketing Application for Influenza Nasal Spray Vaccine	04-24	MT
Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-19	CI
Changchun BCHT Biotechnology's 2023 Profit Soars 176% as Revenue Jumps 70%	03-20	MT
BCHT Biotechnology's 2023 Profit Surges 176%; Shares Jump 4%	02-26	MT
Changchun BCHT Biotechnology Co. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23	CI
BCHT Biotechnology Gets Nod to Trial Rabies Vaccine For Humans	12-07	MT
Changchun High-Tech Industry's Unit Gets Nod to Trial Rabies Vaccine	12-07	MT
BCHT Biotechnology to Invest 805 Million Yuan in Flu Vaccine Factory	23-10-24	MT
Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-23	CI
Changchun BCHT Biotechnology Co.(XSSC:688276) added to S&P Global BMI Index	23-09-18	CI
Changchun BCHT Biotechnology Co. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-15	CI
Chuanxin Biomedical Co., Ltd. announced that it has received CNY 150 million in funding from Changchun BCHT Biotechnology Co.	23-06-28	CI

Chart Changchun BCHT Biotechnology Co.

Duration

Period

More charts

Changchun BCHT Biotechnology Co is a China-based innovative biomedical company mainly dedicated to the prevention and treatment of infectious diseases. The Company is mainly engaged in the research and development, production and sales of human vaccines. The Company has three approved vaccine products: varicella vaccine, rabies vaccine and freeze-dried nasal spray flu vaccine. The Company also has other vaccines under development and fully human monoclonal antibody under development for the prevention and control of infectious diseases. The Company mainly conducts business within the domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Changchun BCHT Biotechnology Co.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

31.41 CNY

Average target price

54.56 CNY

Spread / Average Target

+73.72%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-42.69%	1.79B
KYOWA KIRIN CO. LTD.	+14.66%	9.25B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+42.06%	4.45B
SK BIOPHARMACEUTICALS CO., LTD.	-22.01%	4.43B
YUHAN CORPORATION	+8.28%	4.03B
INDIVIOR PLC	+10.13%	2.24B
BETTA PHARMACEUTICALS CO., LTD.	-26.61%	2.18B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+11.64%	2.02B
VELOXIS PHARMACEUTICALS A/S	-0.50%	1.64B
SUPERNUS PHARMACEUTICALS, INC.	-10.19%	1.43B

Specialty & Advanced Pharmaceuticals